The Current Landscape of Immune Checkpoint Blockade in Hepatocellular Carcinoma

This review summarises rapidly emerging clinical data on the promise and challenges of implementing immune checkpoint blockers in hepatocellular carcinoma and discusses the unmet need of biomarkers to predict response or resistance to therapy.

JAMA Oncology